Summary.-In 104 patients with gastric cancer the serum proteins carcinoembryonic antigen (CEA), C-reactive protein (CRP), oil-acid glycoprotein (AGP) (orosomucoid) and a, -antichymotrypsin (ACT) were measured pre-operatively. The estimated median survival of patients with both raised CEA and ACT was only 5 weeks in contrast to 64 weeks for those with both proteins normal. An intermediary group with one of these proteins raised and the other normal had an estimated median survival of 15 weeks. Similar results were obtained by considering a combination of CEA with either AGP or CRP, For these data the results were not explicable in terms of associations between survival time and patient's age, stage, operative procedure, histological classification or site of primary tumour.
DESPITE the considerable advances which have been made in the early diagnosis of gastric cancer by the wider use of endoscopy and improved radiological techniques, most patients with this disease, except those in Japan, are at an advanced stage at their first presentation to hospital, and this is reflected in their short survival time. About 11,000 new cases of stomach cancer are registered each year in England and Wales.
Surgery is the only curative treatment. The survival time of patients eventually dying of the disease is strongly influenced by several factors: whether a potentially curative or only a palliative operation was possible (Cady et al., 1977) , the presence and extent of metastases (Remine & Priestley, 1966) , the histology (Hawley et al., 1970) and the general clinical state of the patients. Study of other forms of cancer has suggested that the pre-treatment levels of certain serum proteins may carry prognostic information additional to that given by clinical factors (Wanebo et al., 1978; O'Quigley et al., 1981) . In this study we have investigated the association between postoperative survival time and pre-treatment levels of carcinoembryonic antigen, albumin and 3 acutereactant proteins (APRPs). To assess to what degree any association discovered was independent of clinical findings, the patient's age, stage, type of operation, site of primary tumour and histological classification were recorded.
PATIENTS AND METHODS
For over 2 years a set of patients in Leeds, diagnosed as having gastric cancer, was studied. At the close of the study, 104 patients had been accrued, their pre-operative blood samples, taken and their subsequent postoperative survival monitored. Diagnosis was generally based upon a combination of radiological examination and endoscopy, though in a small proportion of cases only one investigation w-as used. Histological confirmation was obtained in 92% of cases, the remainder being mainly patients with obvious advanced cancer in whom gastroenterostomy or laparotomy was performed. The main sub-groups into wNhich patients fell are outlined in the Table. Ten ml of blood was taken before surgery, allowed to clot and the serum separated and stored at -20°C until analysed. Carcinoembryonic antigen (CEA) was measured in duplicate on unextracted serum, using a solid-phase double-antibody technique (Hammarstrdm & Berglund, 1979) . This assay gave an upper limit of normal of 8 ng/ml, which corresponded to a level of 5 ng/ml using the Abbott CEA-EIA assay on perchloric acid-extracted sera. In this study a CEA > 10 ng/ml was considered to be high.
Serum cxl-antichymotrypsin (ACT), oil-acid glycoprotein (AGP) and C-reactive protein (CRP) were measured by single radial immunodiffusion (Mancini et al., 1965 ) using antisera and standards obtained from Behringwerke, Marburg, Germany and Seward Laboratories, London. The upper limits of normal for these proteins were defined as: ACT 0-8 g/l; AGP 1-4 g/l and CRP 10 mg/l. These levels were adopted on the basis of earlier experience in a study of elderly patients (Bastable et al., 1979) . Serum albumin was measured colorimetrically in multi-channel analysers, 37 g/l being the lower limit of normal.
Stati8tical approach. The methods described by Peto et al. (1977) were used to examine differences in survival between groups defined according to the different serum levels. Whereas these methods are appropriate in the case of randomized clinical trials, here they are being used to examine prognostic factors. The approach should therefore be regarded as an exploratory one, in which the significance levels (P values) would not have their usual interpretation. This is particularly so when a number of questions are being asked of the data. None the less, all else being equal, small P values suggest the implausibility that observed differences arose by random variation. It is because all else was not usually equal that stratification as described in the above mentioned paper was carried out. This helped to show whether any differences were simply explicable by clinical imbalance in the groups.
RESULTS
All the patients in this study irrespective of the stratification variables outlined in the Table, were divided into 2 groups according to whether the CEA was within normal limits or elevated (> 10 ng/ml). The survival experience of the 2 groups was significantly different; the median survival in the patients with a normal CEA was 28 weeks and in the patients with a raised CEA it was 10 weeks (P < 0-001). Applying a similar procedure, when the patients were divided into 2 groups according to whether a particular acute-phase reactant protein (APRP) was elevated or normal, it was observed that the patients with normal APRP levels had a significantly longer survival than those with raised levels. This was true for all 3 APRPs, ACT being the most marked. Forty-six patients witha normal ACT had a median survival of 53 weeks, compared to 59 patients with a raised value and median survival of only 9 weeks (P < 0001). The separations achieved with AGP and CRP were very similar to one another, in that the median survival time in the non-raised group was >40 weeks, compared with < 12 weeks in the elevated group (P < 0 01).
It was noted that if any one of ACT, AGP or CRP were raised, there was a high probability that the other 2 APRPs would also be raised. On the other hand, there was a lack of correlation between a high CEA and high APRP. Since both were shown to have prognostic value, this lack of correlation suggested that a Approach, it was possible to assess the probabilities importance of the CEA/ACT combination xe levels of once these other factors had been accounted for. The CEA/ACT index on its own had P < 0001. Accounting both for stage operative procedure, separately, Ler might be a P = 0 00 1. Accounting for stage and operaeparating the tive procedure together, P=0 002, sugJariate alone. gesting that this index carries prognostic se sub-divided information in various clinical circum-3 whether the stances. There was no evidence of interacboth elevated, tions; i.e., the effect was broadly similar , an APRP across all sub-groups containing enough variate was patients to gauge the difference. In fact, was tried for stage and operative procedure are so each APRP. highly correlated it is only necessary to n all 3 cases. consider one of them. The levels of )mbination of serum albumin did not appear to carry .uced the best much prognostic information. (Gilbertson, 1969; Lundh et al., 1974; Dupont et al., 1978) . There have been many studies of the factors that influence prognosis in gastric cancer. Stage is obviously important (Adashek et al., 1979) ; on the other hand, opinion varies on the role of structural features and histological differentiation of the tumour (Black et al., 1971; Lauren, 1965; Syrjanen & Hjelt, 1977) , the type of resection (Eker & Ejskind, 1960; Lewin, 1960; Lumpkin et al., 1964) , tumour site, size and type (Cady et al., 1977; Remine Priestley, 1966; Hawley et al., 1970) and length of history (Barber et al. 1961; Swynnerton & Truelove, 1952) . The combination of stage and histology has previously provided the surest basis for assessing prognosis and is made after laparotomy.
The pre-operative assessment of prognosis in patients without evident metastasis is very difficult; often the full extent of the disease is seen only at laparotomy or after the study of the resected specimen. This clearly adds to the surgeon's difficulty in deciding the most suitable operative procedure.
The tests described in this paper have the advantage of giving prognostic information before surgery, and can be provided within a few days. Furthermore the statistical analysis has indicated that this system may still have prognostic significance even after stage has been taken into account. There is growing evidence that in some forms of cancer high CEA carries a high probability of a poor prognosis, for example, pre-operative CEA in colon cancer and the time to recurrence are inversely correlated (Wanebo et at., 1978) . A weak negative association between pre-operative CEA levels and survival in stomach cancer has been reported . Similarly, in breast cancer (Steward et al., 1974) , lung cancer (Vincent et al., 1975; Ford et al., 1981) and gynaecological cancer (van Nagell et al., 1977) a raised CEA carries a high probability of extensive disease and a poor prognosis. Acute-phase reactant proteins rise nonspecifically in many forms of cancer (Cooper & Stone, 1979) . Raised APRPs before treatment are associated with a poor prognosis, as judged by survival, in category T3 and T4 bladder cancer (O'Quigley et al., 1981) and in carcinoma of the bronchus (Bradwell et al., 1980) . This preliminary study suggests that a simple combination of tests may add to the clinician's knowledge about his patient. It is perhaps permature to say that these tests should influence clinical decisions; e.g. to substitute a simple procedure such as laparoscopy for laparotomy when the evidence suggests a poor prognosis, in the absence of symptoms requiring surgical palliation. A more practical application would seem to be as an aid to stratification for chemotherapy trials.
